These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 8472978)
21. Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs. Sasaki N; Matsuno K; Okabe S Aliment Pharmacol Ther; 2000 Apr; 14(4):479-88. PubMed ID: 10759628 [TBL] [Abstract][Full Text] [Related]
22. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog. de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545 [TBL] [Abstract][Full Text] [Related]
23. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Jin HO; Lee KY; Chang TM; Chey WY; Dubois A Dig Dis Sci; 1994 Nov; 39(11):2306-14. PubMed ID: 7956596 [TBL] [Abstract][Full Text] [Related]
24. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926 [TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide. Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192 [TBL] [Abstract][Full Text] [Related]
26. Effects of lorglumide on gastrin- and peptone-stimulated gastric acid secretion in rats. van de Brug FJ; Jansen JB; Kuijpers IJ; Lamers CB Life Sci; 1990; 47(26):2459-64. PubMed ID: 2263169 [TBL] [Abstract][Full Text] [Related]
27. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist. Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406 [TBL] [Abstract][Full Text] [Related]
28. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats. Varga G; Campbell DR; Bussjaeger LJ; Solomon TE Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323 [TBL] [Abstract][Full Text] [Related]
29. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. Konturek JW; Bielański W; Konturek SJ; Domschke W J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296 [TBL] [Abstract][Full Text] [Related]
30. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Tarnasky PR; Kovacs TO; Sytnik B; Walsh JH Dig Dis Sci; 1993 Sep; 38(9):1681-7. PubMed ID: 8359081 [TBL] [Abstract][Full Text] [Related]
31. Inhibition by somatostatin of gastrin release and gastric acid responses to meals and to pentagastrin in man. Phillip J; Domschke S; Domschke W; Urbach HJ; Reiss M; Demling L Scand J Gastroenterol; 1977; 12(3):261-5. PubMed ID: 866987 [TBL] [Abstract][Full Text] [Related]
32. Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula. Takemoto Y; Yuki H; Nishida A; Ito H; Kobayashi-Uchida A; Takinami Y; Akuzawa S; Ohta M; Satoh M; Semple G; Miyata K Arzneimittelforschung; 1998 Apr; 48(4):403-7. PubMed ID: 9608884 [TBL] [Abstract][Full Text] [Related]
33. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans. Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712 [TBL] [Abstract][Full Text] [Related]
34. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease. Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051 [TBL] [Abstract][Full Text] [Related]
35. Regulation of gastric acid secretion by gastrin in duodenal ulcer patients and healthy subjects. Eysselein VE; Kovacs TO; Kleibeuker JH; Maxwell V; Reedy T; Walsh JH Gastroenterology; 1992 Apr; 102(4 Pt 1):1142-8. PubMed ID: 1551523 [TBL] [Abstract][Full Text] [Related]
36. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones. Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015 [TBL] [Abstract][Full Text] [Related]
37. Studies on vagal activation of gastric acid secretion in man. Stenquist B Acta Physiol Scand Suppl; 1979; 465():1-31. PubMed ID: 291298 [TBL] [Abstract][Full Text] [Related]
38. Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Katschinski M; Dahmen G; Reinshagen M; Beglinger C; Koop H; Nustede R; Adler G Gastroenterology; 1992 Aug; 103(2):383-91. PubMed ID: 1634057 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat. Hirst BH; Elliott KJ; Ryder H; Szelke M Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479 [TBL] [Abstract][Full Text] [Related]
40. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers. Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]